相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy
Tomas Majtan et al.
FASEB JOURNAL (2019)
Classical homocystinuria: From cystathionine beta-synthase deficiency to novel enzyme therapies
Erez M. Bublil et al.
BIOCHIMIE (2019)
Enzyme replacement therapy prevents loss of bone and fat mass in murine homocystinuria
Tomas Majtan et al.
HUMAN MUTATION (2018)
Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria
Tomas Majtan et al.
MOLECULAR THERAPY (2018)
Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency
Andrew A. M. Morris et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria
Tomas Majtan et al.
FASEB JOURNAL (2017)
Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria
Tomas Majtan et al.
BIOMACROMOLECULES (2017)
Gastrointestinal Issues in Liver Disease
Jody C. Olson et al.
CRITICAL CARE CLINICS (2016)
Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions
Tomas Majtan et al.
CURRENT DRUG TARGETS (2016)
Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence
J. David Spence
INTERNATIONAL JOURNAL OF STROKE (2016)
Measurement of Endothelium-Dependent Vasodilation in Mice-Brief Report
Dominik Schuler et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Liver regeneration
Shennen A. Mao et al.
TRANSLATIONAL RESEARCH (2014)
Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia
Sanjana Dayal et al.
BLOOD (2012)
Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: Implications for identifying coagulopathic mechanisms in humans
Rita Marchi et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Coagulopathy in liver diseases
A. Pluta et al.
ADVANCES IN MEDICAL SCIENCES (2010)
A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment
Kenneth N. Maclean et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment
Kenneth N. Maclean et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Mouse models of cystathionine β-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia
Sapna Gupta et al.
FASEB JOURNAL (2009)
Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia
Sanjana Dayal et al.
BLOOD (2006)
Liver failure and neurologic disease in a patient with homocystinuria
SE Snyderman
MOLECULAR GENETICS AND METABOLISM (2006)
Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation - The role of homocysteine
D Poli et al.
STROKE (2005)
Expression of mutant human cystathionine β-synthase rescues neonatal lethality but not homocystinuria in a mouse model
LQ Wang et al.
HUMAN MOLECULAR GENETICS (2005)
Classical homocystinuria: Vascular risk and its prevention
S Yap
JOURNAL OF INHERITED METABOLIC DISEASE (2003)
Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction
T Sasaki et al.
STROKE (2002)
Vascular outcome in patients with homocystinuria due to cystathionine β-synthase deficiency treated chronically -: A multicenter observational study
S Yap et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
分享论文
